Seyed Hamid Jalalian

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The clinical use of Epirubicin (Epi), as an anthracycline drug, is limited because of its cardiotoxicity. Here, an Epirubicin (Epi)-modified polyvalent aptamer system (MPAS) conjugate was developed for the treatment of both murine colon carcinoma cells (C26) and breast cancer cells (MCF-7). Epi-MPAS conjugate formation was evaluated by fluorometric(More)
  • 1